Ekso Bionics Holdings, Inc. (LON:0IFR)
London flag London · Delayed Price · Currency is GBP · Price in USD
4.270
-0.228 (-5.07%)
At close: May 30, 2025

Ekso Bionics Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.176.498.6420.5340.41
Cash & Short-Term Investments
1.176.498.6420.5340.41
Cash Growth
-82.00%-24.83%-57.92%-49.20%214.15%
Accounts Receivable
7.317.245.654.634.66
Inventory
4.824.575.055.192.24
Other Current Assets
0.750.540.880.70.49
Total Current Assets
14.0518.8420.2131.0447.8
Net Property, Plant & Equipment
1.822.3733.991.21
Other Intangible Assets
3.54.584.895.22-
Goodwill
0.430.430.430.43-
Other Long-Term Assets
0.310.430.390.230.16
Total Assets
20.1126.6528.9240.949.17
Accounts Payable
1.431.551.853.153.11
Accrued Expenses
1.782.352.662.282.3
Short-Term Debt
2.01----
Current Portion of Long-Term Debt
1.251.251.252.31-
Current Portion of Leases
0.440.430.360.340.23
Unearned Revenue
1.731.961.991.121.22
Total Current Liabilities
8.647.548.129.26.86
Long-Term Debt
0.83.854.833.771.99
Long-Term Leases
0.150.450.721.09-
Other Long-Term Liabilities
1.52.12.641.413.1
Total Long-Term Liabilities
2.456.418.26.265.09
Total Liabilities
11.0813.9516.3115.4611.95
Common Stock
0.040.020.020.010.01
Additional Paid-in Capital
272.08262.2251.58248.81246.09
Accumulated Other Comprehensive Income
-0.690.960.160.56-0.02
Retained Earnings
-262.4-250.48-239.15-223.95-208.87
Shareholders' Equity
9.0312.7112.6125.4437.22
Total Liabilities & Equity
20.1126.6528.9240.949.17
Total Debt
4.645.987.177.512.22
Net Cash (Debt)
-3.480.511.4713.0238.18
Net Cash Growth
--65.31%-88.71%-65.90%323.98%
Net Cash Per Share
-1.430.381.5915.0746.68
Book Value
9.0312.7112.6125.4437.22
Book Value Per Share
3.729.4513.6429.4445.50
Tangible Book Value
5.17.77.2819.7937.22
Tangible Book Value Per Share
2.105.737.8822.9145.50
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.